Junicef T 250mg/31.25mg Injection
Marketer
Junifer Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Junicef T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be overseen by a medical professional; adhere strictly to the prescribed dosage schedule. Complete the entire treatment course, even with symptom improvement; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your doctor of all concurrent medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, proper nutrition, and hydration are crucial for optimal recovery. Your doctor may order blood work and diagnostic tests to monitor therapeutic response.
Primary Ingredients of Junicef T 250mg/31.25mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Junicef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Junicef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Junicef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Junicef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Junicef T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum injection (Junicef T 250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Junicef T 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Junicef T 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Junicef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Junicef T 250mg/31.25mg Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Junicef T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Junicef T 250mg/31.25mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Dosage alteration for Junicef T 250mg/31.25mg Injection is unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Junicef T 250mg/31.25mg Injection :
Omitting a scheduled Junicef T 250mg/31.25mg Injection requires immediate physician consultation.
Facts to Know About Junicef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently